On Invalid Date, Abeona Therapeutics (NASDAQ: ABEO) reported Q1 2023 earnings per share (EPS) of -$0.54, up 85.79% year over year. Total Abeona Therapeutics earnings for the quarter were -$9.11 million. In the same quarter last year, Abeona Therapeutics's earnings per share (EPS) was -$3.80.
As of Q2 2023, Abeona Therapeutics's earnings has grown year over year. Abeona Therapeutics's earnings in the past year totalled -$31.79 million.
What was ABEO's revenue last quarter?
On Invalid Date, Abeona Therapeutics (NASDAQ: ABEO) reported Q1 2023 revenue of $0.00 up 100% year over year. In the same quarter last year, Abeona Therapeutics's revenue was $346.00 thousand.
What was ABEO's revenue growth in the past year?
As of Q2 2023, Abeona Therapeutics's revenue has grown -68.08% year over year. This is 137.86 percentage points lower than the US Biotechnology industry revenue growth rate of 69.78%. Abeona Therapeutics's revenue in the past year totalled $1.07 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.